Watch PRI’s webinar: The Biosimilar Promise: How Biosimilars Reform Could Save Patients and Taxpayers Even More

Watch PRI’s webinar: The Biosimilar Promise: How Biosimilars Reform Could Save Patients and Taxpayers Even More

Low-cost biosimilars generated $19 billion in savings value in today’s dollars in 2023. But obstacles in the current drug pricing system meant that billions of dollars in potential savings were left unrealized. Join the Pacific Research Institute’s Center for Medical Economics and Innovation and panel of experts for a brief, informative webinar discussing how potential reforms can improve competition, generate more savings, and better serve patients and taxpayers.